Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group plans to increase its stake in a pharmaceutical unit in Chengdu for a consideration of $10.8 million.
The company already holds a 93% stake in the target company, while the proposed acquisition will increase the same to 100%.
In another proposal by a Chinese company, Cachet Pharmaceutical, a majority stake of 51% is intended to be acquired in a pharmaceutical company based in Xi’an, China.
The deal value is proposed to be ¥18 million ($2.67 million).
US-based Antegrin Therapeutics and Cascadia Therapeutics have announced the completion of their merger.
The merged entity, named Indalo Therapeutics, aims to develop treatments for fibrotic diseases.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData